Literature DB >> 24191292

HIV prevalence and related risk behaviours among female sex workers in Iran: results of the national biobehavioural survey, 2010.

Leily Sajadi1, Ali Mirzazadeh, Soodabeh Navadeh, Mehdi Osooli, Razieh Khajehkazemi, Mohammad Mehdi Gouya, Noushin Fahimfar, Omid Zamani, Ali-Akbar Haghdoost.   

Abstract

OBJECTIVES: To determine the prevalence of HIV and related behavioural risks among Iranian female sex workers (FSW) via the first national biobehavioural surveillance survey.
METHODS: In 2010, 1005 FSW were approached and 872 recruited using facility-based sampling from 21 sites in 14 cities in Iran. We collected dried blood samples and conducted face-to-face interviews using a standardised questionnaire. Data were weighted based on the response rate and adjusted for the clustering effect of the sampling site. Adjustment was performed by weighting based on the sampling fraction of each site using a prior estimate of its total size of the FSW population.
RESULTS: The prevalence of HIV infection (95% CI) was 4.5% (2.4 to 8.3) overall, 4.8% (2.2 to 9.8) among those who had reported a history of drug use and 11.2% (5.4 to 21.5) among those who had a history of injection drug use. The frequencies of condom use in the last sexual act with paying clients and non-paying partners were 57.1% and 36.3%, respectively. Any drug use was reported by 73.8% of participants, and among this subgroup, 20.5% had a history of injection drug use.
CONCLUSIONS: The prevalence of HIV was considerable among FSW particularly those who had a history of drug injection. A combination of prevention efforts addressing unsafe sex and injection are needed to prevent further transmission of HIV infection.

Entities:  

Keywords:  Condoms; Drug Misuse; HIV

Mesh:

Substances:

Year:  2013        PMID: 24191292      PMCID: PMC3841765          DOI: 10.1136/sextrans-2013-051028

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


Introduction

Iran's HIV epidemic has been characterised by the spread of infection among people who inject drugs (PWID) with dramatic outbreaks noted in prisons in the mid 1990 s.1 Such outbreaks pushed health authorities to scale up the HIV response by expanding harm reduction services in and outside prisons, voluntary counselling and testing (VCT) sites for HIV (from 231 sites in 2006 to 476 in 2010), and sexually transmitted disease (STD) clinics serving vulnerable women including female sex workers (FSW). These efforts led to an increase in the number of identified HIV cases to 23 497 cases by 2012, with the dominant mode of transmission still drug injection (69.8%). The case notifications, however, indicated an increasing contribution of unsafe sex—up to 20.8% for those cases identified in 2010.2 Based on expert opinion, it is estimated that overall, 80 000 active FSW are living in Iran,3 4 while 7% of men aged between 18 to 45 have had sexual contact with a FSW over the last year.5 A recent mathematical modelling exercise estimated that approximately 1100 FSW in Iran could be infected with HIV by 2014.6 However, the epidemiology of HIV and high risk behaviours among FSW are not yet well studied due to the highly stigmatised and illegal nature of sex work, and further of any sex outside of marriage in Iran. The aim of this first national biobehavioural surveillance survey among FSW was to assess the prevalence of HIV infection and related risky behaviours in this special subpopulation.

Methods

This study was envisioned as the first round of ongoing biobehavioural surveillance surveys7 for the FSW populations in Iran, and was conducted between April and July 2010 in 21 sites in 14 cities. The cities were chosen to be geographically representative of all regions in the country. The recruiting sites were a combination of non-governmental organisations and public STD clinics serving vulnerable women (13 sites) and drop-in centres serving men and women, including FSW (8 sites). Given the local health department surveillance team inputs, we chose a maximum of two facilities per city for the study, according to the capacity of staff to consent, enrol and interview the participants. Of those seeking routine services at each recruiting site, 30–45 eligible FSW were recruited using convenience sampling. FSW were approached by a trained (peer) recruiter who verified eligibility criteria (age ≥18 years, selling sex for money, drugs, or goods in the last 12 months, and a history of practising sex work for at least 6 months) and explained the study benefits and potential harms. The study protocol and procedures were reviewed and approved by the Research Review Board at Kerman University of Medical Sciences (2010—no. 90/122). Our questionnaire on demographic characteristics, history of sex work, and related sex and drug use risks was based on previous questionnaires developed by Family Health International3 with inclusion of other local and international indicators. Among additional indicators included were engagement in temporary marriage (Sighe), local venues that FSW use for either finding clients or having sex, history of being in prison and knowledge of available sites for HIV testing. We also asked about sexually transmitted infection syndromes and treatment seeking patterns. After obtaining verbal informed consent, every FSW was anonymously interviewed by a trained interviewer. Upon providing a separate consent for HIV testing, a dried blood spot (DBS) specimen was also collected. An incentive (US $2; except in Tehran, which was US $3) was given as a gift for participation. A unique 10-digit code linked each questionnaire and its corresponding DBS. Every participant was able to obtain her HIV test result after providing the unique identifier code to the consulter either at the recruitment site or in the neighbourhood local VCT site. Positive cases were linked to services based on routine ongoing procedures at VCT centres. HIV seropositivity was assessed using ELISA. Each DBS was considered positive if it had two ELISA reported results that were higher than the cut-off point. The first ELISA was performed using a bio Mérieux Vironostika Uni-Form II Ag/Ab kit; for the second test, a Bio-Rad Genscreen Plus HIV Ag-Ab kit was used. A third test was performed for discordant results. Quality control testing was performed by the reference laboratory (Pasteur Institute of Iran) on 10% of samples randomly selected from all specimens. Data were weighted and adjusted for the clustering effect of the sampling sites. Since we recruited FSW from the sites, we considered the sites as sampling units to take into account such clustering effects in our analysis. Each site was serving a different number of FSW, but we recruited a fixed number of 30–45 FSW per site. To adjust for the differential sampling probabilities, we conducted a weighted analysis. Point estimates and 95% CIs were calculated. The χ2 test was used to assess correlates of HIV infection. Statistical significance was set at p<0.05. All analyses were performed using STATA V.10 (Stata Corp.).

Results

We initially approached 1005 FSW; from that group the entire dataset from one province (100 FSW) was excluded mainly because of low-quality data collection based on the feedback of the provincial supervisor and the results of our external evaluation. From the remaining 12 provinces, 32 FSW were excluded because of ineligibility and 1 because of refusal to give consent. Of 872 eligible FSW that consented for the interview, 817 (93.7%) also consented for blood draw. The mean age of the respondents was 31.8 years (SD 9.1, median 30 years). Ever being married was reported by 83.2%, while 35.8% were married at the time of the interview. About half (46.5%) had no education beyond primary school. The mean age at first commercial sex was 24.6 years (SD 7.6, median 24 years). Less than half of FSW (41.6%) had engaged in sex work for more than 4 years. Having another source of income other than sex work was reported by 36.5%. The average number of paying clients reported by FSW in the last 7 days was 3.1 (SD 3.9, median 2 clients). Approximately one-fifth (22.1%) of FSW had never used condoms in any type of sexual contact. Overall, 57.1% of FSW had used condoms in their last sexual contact with a paying client, while 49.1% reported consistent condom use with paying clients over the last month prior to the interview. Of those who reported having a non-paying partner (57.2% of the total), 36.3% had used a condom during the last sexual act and 28% reported consistent condom use with the non-paying partners over the last month prior to the survey. A total of 73.8% reported a history of any drug use. Of these, 63.2% were active drug (other than methadone) users at the time of the survey. Among those with a history of drug use, intravenous drug injection was reported by 20.5%, and 26.6% of these were active injecting drug users at the time of the survey. The mean ages for first drug use and first drug injection were 21.5 years (SD 7.1, median 20 years) and 25.8 years (SD 8.3, median 25 years), respectively. The percentage of FSW who reported high-risk injection (ie, shared syringes or equipment) at their last injection was 11.6%. We found 30 HIV-positive samples. The overall prevalence of HIV infection was 4.5% (95% CI 2.4 to 8.3). HIV prevalence varied substantially between the different sites/cities with a range of 0% to 28.6%, but with wide and overlapping CIs. The prevalence of HIV was 4.8% among FSW who reported a history of any drug use, and 11.2% for those who had a history of drug injection. We found that the prevalence of HIV infection was significantly associated with having a history of drug injection and having another source of income in addition to sex work. HIV prevalence by several indicators of risk behaviour is presented in table 1.
Table 1

Demographic and behavioural characteristics and the weighted HIV prevalence among FSW in Iran, 2010

Behavioural factorsN (%)HIV prevalence (95% CI)*p Value†
Current age
 18–24210 (23.8)00.085
 25–34362 (41.7)5.8 (2.9 to 11.4)
 ≥35292 (34.5)6.0 (2.8 to 12.3)
Current marital status
 Married/ ever married697 (81.6)5.0 (2.6 to 9.5)0.224
 Single172 (18.4)1.9 (0.4 to 8.9)
Age at first commercial sex
 ≤1547 (7.7)00.132
 16–20223 (28.8)3.7 (1.1 to 11.6)
 21–25216 (25.9)1.6 (0.4 to 5.6)
 ≥26313 (37.6)7.6 (3.4 to 16.1)
Having another source of income in addition to sex work
 Yes298 (36.5)7.1 (3.5 to 13.9)0.027
 No550 (63.5)3.2 (1.5 to 6.8)
Number of paying clients in the last 7 days
 None440 (53.9)5.2 (2.7 to 9.8)0.185
 1–2233 (27.9)2.6 (0.9 to 7.2)
 ≥2151 (18.2)2.1 (0.4 to 9.6)
Condom use during last sexual act with paying clients
 Yes531 (57.1)3.9 (1.9 to 7.8)0.405
 No310 (42.9)5.6 (2.4 to 12.8)
Having non-paying partners
 Yes481 (57.2)4.7 (2.2 to 9.8)0.734
 No389 (42.8)4.1 (1.9 to 8.7)
Having ever used drugs
 Yes624 (73.8)4.8 (2.2 to 9.8)0.307
 No247 (26.2)2.8 (1.3 to 5.9)
Having ever injected drugs
 Yes127 (20.5)11.2 (5.4 to 21.5)0.003
 No497 (79.5)3.1 (1.5 to 6.4)

*Weighted analysis based on sampling probability and clustering effects.

†Using χ2 test.

‡Among those who had a history of any drug use.

Demographic and behavioural characteristics and the weighted HIV prevalence among FSW in Iran, 2010 *Weighted analysis based on sampling probability and clustering effects. †Using χ2 test. ‡Among those who had a history of any drug use.

Discussion

The prevalence of HIV in our first national biobehavioural surveillance survey of FSW was 4.5%, considerably higher than the no infections (0.0%) and 2.7% prevalence measured in previous surveys among FSW in Iran.8 In a recent survey among FSW in Shiraz using respondent driven sampling, HIV prevalence was reported at 4.7%9 which is comparable to what we observed in our study. It is of concern that we have documented high levels of drug use and injection drug use in this population. The high rate of drug injection in this sample illustrates a link between FSW and PWID; the population most severely affected by HIV in Iran. HIV prevalence among FSW who injected drugs was more than three times that among those who did not inject drugs, and it was comparable to HIV prevalence among PWID in Iran (15.1%).2 The high prevalence of injection drug use in our study was also similar to another study among FSW in Iran,10 corroborating the role of drug injection in the spread of HIV among and between other high-risk groups in Iran. While it is reasonable to assume that a substantial fraction of HIV infections among FSW were acquired through drug injection rather than unprotected sex, the potential for further onward transmission from FSW to their clients and non-client partners appears high, given the rather low level of condom use among our study population. Fortunately, for now, the sexual mode of transmission in commercial sex networks does not yet appear to be a major driver of the epidemic in this country according to HIV case reporting and other estimates. We found a lower mean number of paying clients per FSW per week in comparison with another study in Iran (5 to 9 clients),8 but this was higher in comparison to another recent study (2.6 clients).10 The observed condom use during last sexual intercourse was less than that in a recent study in 2010, using respondent driven sampling to recruit 177 FSW in Kerman, which reported 83.1% condom use during last sexual contact with a client.10 In other studies in the Middle East and North Africa region, condom use in last sexual contact with paying clients varied between 24% (FSW in Hargeisa, Somalia11) to 92.0% (street-based FSW in Lebanon12). In terms of number of clients over the last 7 days, in Somalia it was reported as a median of three paying clients, which is just above what we observed.11 FSW who had another source of income beyond selling sex were more likely to be HIV positive. This finding should be explored in further studies to examine whether such FSW are involved in other forms of risky behaviours. Incidentally, these FSW reported more non-paying partners than clients (given the fact that condom use rate is less among non-paying partners than clients; 36.3% vs. 57.1%). We recognise several limitations in our study. First, because the sample was recruited from health and social service facilities, the measured HIV prevalence and risk behaviours may not be representative of all FSW in Iran. Facilities are likely to include those FSW with potential health problems stemming from longer-term injection drug use or HIV infection itself. Therefore, HIV prevalence could be overestimated in our sample compared to a previous study.8 Moreover, our study was conducted over 21 sites including 13 that served FSW and other vulnerable women. The remaining eight sites were chosen purposefully to be geographically representative for all regions in the country, but feasibility was a factor in choosing specific sites within each region. To be comprehensive, we recruited from non-governmental and public health centres to capture all subgroups of the target population that are linked to services. These choices and factors may have affected the representativeness of our sample. A recent validation study in Iran suggested that FSW tend to underestimate the number of clients and overestimate condom use with clients in the context of face to face interviews.13 A gold-standard survey methodology or truly representative sample of all FSW in the major cities of Iran is lacking, and is likely to remain a challenge for many years to come. We present the findings of the first survey of FSW in the nation as a baseline to improve upon in the future. To the extent that future surveys in the same cities, sites and facilities may reproduce comparable samples, the data presented here may serve as a basis for tracking the epidemic in this vulnerable population over time. In the meantime, our data demonstrate that HIV infection among FSW is a reality and is contributing to the overall epidemic in Iran. Multifaceted prevention interventions (ie, addressing 100% condom use and clean syringe use) are urgently needed in Iran. HIV prevalence was 4.5% among female sex workers recruited through a national study from drop-in centres, harm reduction centres and shelters. Female sex workers who injected drugs were more than three times as likely to be infected as those who did not inject drugs; this suggests that a considerable fraction of HIV infections among these female sex workers were acquired through drug injection.
  7 in total

1.  HIV/AIDS among female sex workers, injecting drug users and men who have sex with men in Lebanon: results of the first biobehavioral surveys.

Authors:  Ziyad Mahfoud; Rema Afifi; Sami Ramia; Danielle El Khoury; Kassem Kassak; Farah El Barbir; Maguy Ghanem; Mostafa El-Nakib; Jocelyn DeJong
Journal:  AIDS       Date:  2010-07       Impact factor: 4.177

2.  HIV prevalence and characteristics of sex work among female sex workers in Hargeisa, Somaliland, Somalia.

Authors:  Kelsi Kriitmaa; Adrienne Testa; Mohamed Osman; Ivana Bozicevic; Gabriele Riedner; Jacqueline Malungu; Greg Irving; Ismail Abdalla
Journal:  AIDS       Date:  2010-07       Impact factor: 4.177

3.  Accuracy of HIV-related risk behaviors reported by female sex workers, Iran: a method to quantify measurement bias in marginalized populations.

Authors:  Ali Mirzazadeh; Ali Akbar Haghdoost; Saharnaz Nedjat; Soodabeh Navadeh; Willi McFarland; Kazem Mohammad
Journal:  AIDS Behav       Date:  2013-02

Review 4.  Modeling of human immunodeficiency virus modes of transmission in Iran.

Authors:  Maryam Nasirian; Fardad Doroudi; Mohammad Mahdi Gooya; Abbas Sedaghat; Ali Akbar Haghdoost
Journal:  J Res Health Sci       Date:  2012-12-13

5.  The prevalence of human immunodeficiency virus and sexually transmitted infections among female sex workers in Shiraz, South of Iran: by respondent-driven sampling.

Authors:  Parvin Afsar Kazerooni; Nasrin Motazedian; Mohammad Motamedifar; Mehrab Sayadi; Mojghan Sabet; Mahmood Amini Lari; Kianoush Kamali
Journal:  Int J STD AIDS       Date:  2013-07-19       Impact factor: 1.359

6.  Size Estimation of Groups at High Risk of HIV/AIDS using Network Scale Up in Kerman, Iran.

Authors:  Mostafa Shokoohi; Mohammad Reza Baneshi; Ali-Akbar Haghdoost
Journal:  Int J Prev Med       Date:  2012-07

7.  HIV, HSV2 and Syphilis Prevalence in Female Sex Workers in Kerman, South-East Iran; Using Respondent-Driven Sampling.

Authors:  S Navadeh; A Mirzazadeh; L Mousavi; Aa Haghdoost; N Fahimfar; A Sedaghat
Journal:  Iran J Public Health       Date:  2012-12-01       Impact factor: 1.429

  7 in total
  37 in total

1.  Remaining Gap in HIV Testing Uptake Among Female Sex Workers in Iran.

Authors:  Mostafa Shokoohi; Atefeh Noori; Mohammad Karamouzian; Hamid Sharifi; Razieh Khajehkazemi; Noushin Fahimfar; Samira Hosseini-Hooshyar; Parvin Afsar Kazerooni; Ali Mirzazadeh
Journal:  AIDS Behav       Date:  2017-08

2.  HIV prevalence and associated factors among female sex workers in Iran: a bio-behavioral survey in 2020.

Authors:  Neda Izadi; Mohammad-Mehdi Gouya; Samaneh Akbarpour; Bushra Zareie; Yousef Moradi; Parvin Afsar Kazerooni; Marzieh Mahboobi; Parisa Mohseni; Ghobad Moradi
Journal:  AIDS Behav       Date:  2022-09-12

3.  Drug use patterns and associated factors among female sex workers in Iran.

Authors:  Mostafa Shokoohi; Mohammad Karamouzian; Greta R Bauer; Hamid Sharifi; Samira Hosseini Hooshyar; Ali Mirzazadeh
Journal:  Addict Behav       Date:  2018-09-30       Impact factor: 3.913

4.  Sexual and reproductive health needs of HIV-positive people in Tehran, Iran: a mixed-method descriptive study.

Authors:  Saharnaz Nedjat; Babak Moazen; Farimah Rezaei; Shayesteh Hajizadeh; Reza Majdzadeh; Hamid Reza Setayesh; Minoo Mohraz; Mohammad Mehdi Gooya
Journal:  Int J Health Policy Manag       Date:  2015-03-19

Review 5.  HIV in Iran: onset, responses, and future directions.

Authors:  SeyedAhmad SeyedAlinaghi; Leila Taj; Elham Mazaheri-Tehrani; Sara Ahsani-Nasab; Negin Abedinzadeh; Willi McFarland; Minoo Mohraz; Ali Mirzazadeh
Journal:  AIDS       Date:  2021-03-15       Impact factor: 4.632

6.  Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors:  Christopher J L Murray; Katrina F Ortblad; Caterina Guinovart; Stephen S Lim; Timothy M Wolock; D Allen Roberts; Emily A Dansereau; Nicholas Graetz; Ryan M Barber; Jonathan C Brown; Haidong Wang; Herbert C Duber; Mohsen Naghavi; Daniel Dicker; Lalit Dandona; Joshua A Salomon; Kyle R Heuton; Kyle Foreman; David E Phillips; Thomas D Fleming; Abraham D Flaxman; Bryan K Phillips; Elizabeth K Johnson; Megan S Coggeshall; Foad Abd-Allah; Semaw Ferede Abera; Jerry P Abraham; Ibrahim Abubakar; Laith J Abu-Raddad; Niveen Me Abu-Rmeileh; Tom Achoki; Austine Olufemi Adeyemo; Arsène Kouablan Adou; José C Adsuar; Emilie Elisabet Agardh; Dickens Akena; Mazin J Al Kahbouri; Deena Alasfoor; Mohammed I Albittar; Gabriel Alcalá-Cerra; Miguel Angel Alegretti; Zewdie Aderaw Alemu; Rafael Alfonso-Cristancho; Samia Alhabib; Raghib Ali; Francois Alla; Peter J Allen; Ubai Alsharif; Elena Alvarez; Nelson Alvis-Guzman; Adansi A Amankwaa; Azmeraw T Amare; Hassan Amini; Walid Ammar; Benjamin O Anderson; Carl Abelardo T Antonio; Palwasha Anwari; Johan Arnlöv; Valentina S Arsic Arsenijevic; Ali Artaman; Rana J Asghar; Reza Assadi; Lydia S Atkins; Alaa Badawi; Kalpana Balakrishnan; Amitava Banerjee; Sanjay Basu; Justin Beardsley; Tolesa Bekele; Michelle L Bell; Eduardo Bernabe; Tariku Jibat Beyene; Neeraj Bhala; Ashish Bhalla; Zulfiqar A Bhutta; Aref Bin Abdulhak; Agnes Binagwaho; Jed D Blore; Berrak Bora Basara; Dipan Bose; Michael Brainin; Nicholas Breitborde; Carlos A Castañeda-Orjuela; Ferrán Catalá-López; Vineet K Chadha; Jung-Chen Chang; Peggy Pei-Chia Chiang; Ting-Wu Chuang; Mercedes Colomar; Leslie Trumbull Cooper; Cyrus Cooper; Karen J Courville; Benjamin C Cowie; Michael H Criqui; Rakhi Dandona; Anand Dayama; Diego De Leo; Louisa Degenhardt; Borja Del Pozo-Cruz; Kebede Deribe; Don C Des Jarlais; Muluken Dessalegn; Samath D Dharmaratne; Uğur Dilmen; Eric L Ding; Tim R Driscoll; Adnan M Durrani; Richard G Ellenbogen; Sergey Petrovich Ermakov; Alireza Esteghamati; Emerito Jose A Faraon; Farshad Farzadfar; Seyed-Mohammad Fereshtehnejad; Daniel Obadare Fijabi; Mohammad H Forouzanfar; Urbano Fra Paleo; Lynne Gaffikin; Amiran Gamkrelidze; Fortuné Gbètoho Gankpé; Johanna M Geleijnse; Bradford D Gessner; Katherine B Gibney; Ibrahim Abdelmageem Mohamed Ginawi; Elizabeth L Glaser; Philimon Gona; Atsushi Goto; Hebe N Gouda; Harish Chander Gugnani; Rajeev Gupta; Rahul Gupta; Nima Hafezi-Nejad; Randah Ribhi Hamadeh; Mouhanad Hammami; Graeme J Hankey; Hilda L Harb; Josep Maria Haro; Rasmus Havmoeller; Simon I Hay; Mohammad T Hedayati; Ileana B Heredia Pi; Hans W Hoek; John C Hornberger; H Dean Hosgood; Peter J Hotez; Damian G Hoy; John J Huang; Kim M Iburg; Bulat T Idrisov; Kaire Innos; Kathryn H Jacobsen; Panniyammakal Jeemon; Paul N Jensen; Vivekanand Jha; Guohong Jiang; Jost B Jonas; Knud Juel; Haidong Kan; Ida Kankindi; Nadim E Karam; André Karch; Corine Kakizi Karema; Anil Kaul; Norito Kawakami; Dhruv S Kazi; Andrew H Kemp; Andre Pascal Kengne; Andre Keren; Maia Kereselidze; Yousef Saleh Khader; Shams Eldin Ali Hassan Khalifa; Ejaz Ahmed Khan; Young-Ho Khang; Irma Khonelidze; Yohannes Kinfu; Jonas M Kinge; Luke Knibbs; Yoshihiro Kokubo; S Kosen; Barthelemy Kuate Defo; Veena S Kulkarni; Chanda Kulkarni; Kaushalendra Kumar; Ravi B Kumar; G Anil Kumar; Gene F Kwan; Taavi Lai; Arjun Lakshmana Balaji; Hilton Lam; Qing Lan; Van C Lansingh; Heidi J Larson; Anders Larsson; Jong-Tae Lee; James Leigh; Mall Leinsalu; Ricky Leung; Yichong Li; Yongmei Li; Graça Maria Ferreira De Lima; Hsien-Ho Lin; Steven E Lipshultz; Shiwei Liu; Yang Liu; Belinda K Lloyd; Paulo A Lotufo; Vasco Manuel Pedro Machado; Jennifer H Maclachlan; Carlos Magis-Rodriguez; Marek Majdan; Christopher Chabila Mapoma; Wagner Marcenes; Melvin Barrientos Marzan; Joseph R Masci; Mohammad Taufiq Mashal; Amanda J Mason-Jones; Bongani M Mayosi; Tasara T Mazorodze; Abigail Cecilia Mckay; Peter A Meaney; Man Mohan Mehndiratta; Fabiola Mejia-Rodriguez; Yohannes Adama Melaku; Ziad A Memish; Walter Mendoza; Ted R Miller; Edward J Mills; Karzan Abdulmuhsin Mohammad; Ali H Mokdad; Glen Liddell Mola; Lorenzo Monasta; Marcella Montico; Ami R Moore; Rintaro Mori; Wilkister Nyaora Moturi; Mitsuru Mukaigawara; Kinnari S Murthy; Aliya Naheed; Kovin S Naidoo; Luigi Naldi; Vinay Nangia; K M Venkat Narayan; Denis Nash; Chakib Nejjari; Robert G Nelson; Sudan Prasad Neupane; Charles R Newton; Marie Ng; Muhammad Imran Nisar; Sandra Nolte; Ole F Norheim; Vincent Nowaseb; Luke Nyakarahuka; In-Hwan Oh; Takayoshi Ohkubo; Bolajoko O Olusanya; Saad B Omer; John Nelson Opio; Orish Ebere Orisakwe; Jeyaraj D Pandian; Christina Papachristou; Angel J Paternina Caicedo; Scott B Patten; Vinod K Paul; Boris Igor Pavlin; Neil Pearce; David M Pereira; Aslam Pervaiz; Konrad Pesudovs; Max Petzold; Farshad Pourmalek; Dima Qato; Amado D Quezada; D Alex Quistberg; Anwar Rafay; Kazem Rahimi; Vafa Rahimi-Movaghar; Sajjad Ur Rahman; Murugesan Raju; Saleem M Rana; Homie Razavi; Robert Quentin Reilly; Giuseppe Remuzzi; Jan Hendrik Richardus; Luca Ronfani; Nobhojit Roy; Nsanzimana Sabin; Mohammad Yahya Saeedi; Mohammad Ali Sahraian; Genesis May J Samonte; Monika Sawhney; Ione J C Schneider; David C Schwebel; Soraya Seedat; Sadaf G Sepanlou; Edson E Servan-Mori; Sara Sheikhbahaei; Kenji Shibuya; Hwashin Hyun Shin; Ivy Shiue; Rupak Shivakoti; Inga Dora Sigfusdottir; Donald H Silberberg; Andrea P Silva; Edgar P Simard; Jasvinder A Singh; Vegard Skirbekk; Karen Sliwa; Samir Soneji; Sergey S Soshnikov; Chandrashekhar T Sreeramareddy; Vasiliki Kalliopi Stathopoulou; Konstantinos Stroumpoulis; Soumya Swaminathan; Bryan L Sykes; Karen M Tabb; Roberto Tchio Talongwa; Eric Yeboah Tenkorang; Abdullah Sulieman Terkawi; Alan J Thomson; Andrew L Thorne-Lyman; Jeffrey A Towbin; Jefferson Traebert; Bach X Tran; Zacharie Tsala Dimbuene; Miltiadis Tsilimbaris; Uche S Uchendu; Kingsley N Ukwaja; Selen Begüm Uzun; Andrew J Vallely; Tommi J Vasankari; N Venketasubramanian; Francesco S Violante; Vasiliy Victorovich Vlassov; Stein Emil Vollset; Stephen Waller; Mitchell T Wallin; Linhong Wang; XiaoRong Wang; Yanping Wang; Scott Weichenthal; Elisabete Weiderpass; Robert G Weintraub; Ronny Westerman; Richard A White; James D Wilkinson; Thomas Neil Williams; Solomon Meseret Woldeyohannes; John Q Wong; Gelin Xu; Yang C Yang; Yuichiro Yano; Gokalp Kadri Yentur; Paul Yip; Naohiro Yonemoto; Seok-Jun Yoon; Mustafa Younis; Chuanhua Yu; Kim Yun Jin; Maysaa El Sayed Zaki; Yong Zhao; Yingfeng Zheng; Maigeng Zhou; Jun Zhu; Xiao Nong Zou; Alan D Lopez; Theo Vos
Journal:  Lancet       Date:  2014-07-22       Impact factor: 79.321

7.  Drug Use and High-Risk Sexual Behaviors of Women at a Drop-In Center in Mazandaran Province, Iran, 2014.

Authors:  Hassan Taghizadeh; Fatemeh Taghizadeh; Mohammad Fathi; Parisa Reihani; Nasrin Shirdel; Seyede Mohaddese Rezaee
Journal:  Iran J Psychiatry Behav Sci       Date:  2015-06-01

8.  Drug Use and Sex Work Among At-risk Women: A Qualitative Study of Initial Factors.

Authors:  Payam Roshanfekr; Roya Noori; Masoumeh Dejman; Zahra Fathi Geshnigani; Hassan Rafiey
Journal:  Iran J Psychiatry Behav Sci       Date:  2015-06-01

Review 9.  The emerging face of the HIV epidemic in the Middle East and North Africa.

Authors:  Ghina R Mumtaz; Gabriele Riedner; Laith J Abu-Raddad
Journal:  Curr Opin HIV AIDS       Date:  2014-03       Impact factor: 4.283

10.  HIV and other sexually transmitted infection research in the Middle East and North Africa: promising progress?

Authors:  Laith J Abu-Raddad; Khalil G Ghanem; Ali Feizzadeh; Hamidreza Setayesh; Jesus Maria Garcia Calleja; Gabriele Riedner
Journal:  Sex Transm Infect       Date:  2013-11       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.